CRWV insider sells shares under 10b5-1 plans
CRWV insiders reported multiple sales of Common Stock under Rule 10b5-1 plans, as shown on Form 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CRWV insiders reported multiple sales of Common Stock under Rule 10b5-1 plans, as shown on Form 144. The filings list several transactions by Brian Venturo and by West Clay Capital LLC across January–March 2026, with per-trade share counts and gross proceeds disclosed.
Insights
Scheduled 10b5-1 sales by an individual and an affiliated entity; routine liquidity activity.
The excerpt lists multiple Rule 10b5-1 sales by Brian Venturo and by West Clay Capital LLC with explicit trade dates, share counts, and gross proceeds (e.g., 281,250 shares on 03/18/2026 for $23,525,409.38). These entries reflect pre-arranged dispositions rather than ad-hoc open-market timing.
Actual impact depends on holdings not fully shown here; subsequent filings could provide post-transaction ownership. Cash-flow treatment is seller proceeds; the excerpt attributes sales to the named persons/entities and identifies the trades as 10b5-1 sales.
Key Figures
Key Terms
10b5-1 regulatory
Form 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CRWV insiders sell according to the Form 144?
Were the CRWV sales executed under a trading plan?
What proceeds were reported for the March 31, 2026 sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.